Servando E. Marron, Tamara Gracia-Cazaña, Francesca Sampogna, Christina Schut, Joerg Kupfer, Florence J. Dalgard, Anthony Bewley, Sylvia van Beugen, Uwe Gieler, Lars Lien, Sonja Ständer, Nienke Vulink, Andrew Y. Finlay, Franz J. Legat, Geraldine Titeca, Gregor B. Jemec, Laurent Misery, Csanad Szabo, Vesna Grivcheva-Panovska, Saskia Spillekom-van Koulil, Flora Balieva, Jacek C. Szepietowski, Adam Reich, Bárbara Roque Ferreira, Andrey Lvov, Dmitry Romanov, Ake Svensson, Ilknur K. Altunay, Andrew R. Thompson, Claudia Zeidler, Lucía Tomas-Aragones, the ESDAP Study Collaborators
{"title":"Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe","authors":"Servando E. Marron, Tamara Gracia-Cazaña, Francesca Sampogna, Christina Schut, Joerg Kupfer, Florence J. Dalgard, Anthony Bewley, Sylvia van Beugen, Uwe Gieler, Lars Lien, Sonja Ständer, Nienke Vulink, Andrew Y. Finlay, Franz J. Legat, Geraldine Titeca, Gregor B. Jemec, Laurent Misery, Csanad Szabo, Vesna Grivcheva-Panovska, Saskia Spillekom-van Koulil, Flora Balieva, Jacek C. Szepietowski, Adam Reich, Bárbara Roque Ferreira, Andrey Lvov, Dmitry Romanov, Ake Svensson, Ilknur K. Altunay, Andrew R. Thompson, Claudia Zeidler, Lucía Tomas-Aragones, the ESDAP Study Collaborators","doi":"10.1111/ijd.17569","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Hidradenitis suppurativa (HS) can severely affect the quality of life (QoL) and is linked to psychological distress, including anxiety, depression, and reduced self-esteem. Stigmatization due to physical appearance may significantly contribute to the psychological burden and impact on QoL for HS patients. This study investigates the association between stigmatization, depression, anxiety, and health- and disease-related variables among HS patients in Europe.</p>\n </section>\n \n <section>\n \n <h3> Patients and methods</h3>\n \n <p>This observational cross-sectional multicenter study was conducted across 22 dermatological outpatient clinics in 17 European countries. Data collected included sociodemographic variables, general health variables, disease-related variables, perceived stigmatization (PSQ), and mental health (PHQ-2, GAD-2).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 5487 dermatological patients, 142 (2.6%) were diagnosed with HS, and data from 135 patients (70.1% women, mean age 38.2 years) who completed the PSQ questionnaire were analyzed. Scores on the stigmatization measure indicated that significant stigmatization levels were present in the sample. Linear regression models revealed a significant relationship between stigmatization and both the duration of HS and the presence of itch. Similar findings were noted for the PSQ “confused/staring behavior” scale with depression. The PSQ “absence of friendly behavior” scale was inversely associated with general health status, whereas the “hostile behavior” scale was positively linked to depression.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>HS patients experience significant stigmatization linked to disease duration, itch, and depression. Comprehensive management, including screening for psychosocial co-morbidity, is essential, as is providing access to psychological interventions that support patients to both manage internal distress and the potential reactions of others.</p>\n </section>\n </div>","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":"64 5","pages":"861-869"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Dermatology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ijd.17569","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Hidradenitis suppurativa (HS) can severely affect the quality of life (QoL) and is linked to psychological distress, including anxiety, depression, and reduced self-esteem. Stigmatization due to physical appearance may significantly contribute to the psychological burden and impact on QoL for HS patients. This study investigates the association between stigmatization, depression, anxiety, and health- and disease-related variables among HS patients in Europe.
Patients and methods
This observational cross-sectional multicenter study was conducted across 22 dermatological outpatient clinics in 17 European countries. Data collected included sociodemographic variables, general health variables, disease-related variables, perceived stigmatization (PSQ), and mental health (PHQ-2, GAD-2).
Results
Of the 5487 dermatological patients, 142 (2.6%) were diagnosed with HS, and data from 135 patients (70.1% women, mean age 38.2 years) who completed the PSQ questionnaire were analyzed. Scores on the stigmatization measure indicated that significant stigmatization levels were present in the sample. Linear regression models revealed a significant relationship between stigmatization and both the duration of HS and the presence of itch. Similar findings were noted for the PSQ “confused/staring behavior” scale with depression. The PSQ “absence of friendly behavior” scale was inversely associated with general health status, whereas the “hostile behavior” scale was positively linked to depression.
Conclusion
HS patients experience significant stigmatization linked to disease duration, itch, and depression. Comprehensive management, including screening for psychosocial co-morbidity, is essential, as is providing access to psychological interventions that support patients to both manage internal distress and the potential reactions of others.
期刊介绍:
Published monthly, the International Journal of Dermatology is specifically designed to provide dermatologists around the world with a regular, up-to-date source of information on all aspects of the diagnosis and management of skin diseases. Accepted articles regularly cover clinical trials; education; morphology; pharmacology and therapeutics; case reports, and reviews. Additional features include tropical medical reports, news, correspondence, proceedings and transactions, and education.
The International Journal of Dermatology is guided by a distinguished, international editorial board and emphasizes a global approach to continuing medical education for physicians and other providers of health care with a specific interest in problems relating to the skin.